Leaflet HYDROXYCHLOROQUINE SULPHATE TABLETS USP 200mg film-coated tablets
Indicated for: autoimmune diseases; malaria
Route of administration: oral
Substance: hydroxychloroquine (antimalarial)
ATC: P01BA02 (Antiparasitic products, insecticides and repellents | Antimalarials | Aminoquinolines)
This medicine may cause vision disturbances.
Hydroxychloroquine is a medication used to treat malaria, as well as autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. It works by modulating the immune response and inhibiting the growth of malaria parasites.
The medication is taken orally, as directed by a doctor.
Side effects may include nausea, headache, visual disturbances, or skin rashes. In rare cases, severe adverse effects such as retinal damage or cardiac toxicity may occur.
Patients should undergo regular ophthalmologic check-ups during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about HYDROXYCHLOROQUINE SULPHATE TABLETS USP 200mg
- Substance: hydroxychloroquine
- Date of last drug list: 01-12-2021
- Commercial code: W66640001
- Concentration: 200mg
- Pharmaceutical form: film-coated tablets
- Quantity: 100
- Product type: original
- Prescription restrictions: X